semaglutide insulin improves glycemic control with automated delivery GLP1 and Semaglutide is Liquid
Description
Novo Nordisk India chief says GLP-1 adoption remains low and the market untapped despite patent expiry opening it to generics
These are still early findings
GLP-1 receptor agonists were originally developed for type 2 diabetes but have shown significant benefits for cholesterol management and metabolic health
A White House spokesman said theories that President Trump sought the drug were baseless speculation
